| Sheri L. Dodd | Chief Executive Officer | FY2025 | |
| Elaine M. Birkemeyer | Chief Financial Officer | FY2025 | |
| Kristie T. Burns | SVP, Marketing and Clinical Affairs | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.